Rua Accelerates Export Strategy, Ceases Manufacturing
Commercial Guest User Commercial Guest User

Rua Accelerates Export Strategy, Ceases Manufacturing

Rua Bioscience announces the export-led company will cease local GMP manufacturing and accelerate its global brand strategy, building its international product pipeline while developing valuable points of difference in the areas of genetic discovery and novel product development. Working with manufacturing partners, Rua expects New Zealand patients will ultimately benefit from a wider range of affordable medicines.

Read More
Rua receives narcotic license through Nimbus Health for distribution and marketing of our first product for Germany
Commercial Guest User Commercial Guest User

Rua receives narcotic license through Nimbus Health for distribution and marketing of our first product for Germany

Rua Bioscience Limited announced today that it has received its narcotic license through Nimbus Health GmbH for distribution and marketing of its first product for the German medicinal cannabis market – a move understood to make Rua the first medicinal cannabis company from New Zealand to take such a step.

Read More
Pharmaceutical Giant Acquires German Distributor Nimbus Health
Guest User Guest User

Pharmaceutical Giant Acquires German Distributor Nimbus Health

Rua Bioscience is pleased to share the news that multi-national pharmaceutical company Dr Reddy's Laboratories Ltd today announced it has entered into a definitive agreement to acquire Nimbus Health. Rua Bioscience was the first New Zealand company to announce a binding export agreement with the reputable distributor in Germany and is Nimbus Health's exclusive New Zealand supplier of medicinal cannabis products.

Read More